Chemoinformaics analysis of CYANO GLUCOPYRANOSIDE
| Molecular Weight | 205.166 | nRot | 2 |
| Heavy Atom Molecular Weight | 194.078 | nRig | 7 |
| Exact Molecular Weight | 205.059 | nRing | 1 |
| Solubility: LogS | -0.179 | nHRing | 1 |
| Solubility: LogP | -1.957 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 24.9367 |
| nHD | 4 | BPOL | 15.0773 |
| QED | 0.361 |
| Synth | 4.192 |
| Natural Product Likeliness | 2.014 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.124 |
| HIA | 0.635 |
| CACO-2 | -5.5 |
| MDCK | 0.000443328 |
| BBB | 0.454 |
| PPB | 0.147514 |
| VDSS | 0.434 |
| FU | 0.786535 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.06 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.32 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.141 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.023 |
| CL | 2.013 |
| T12 | 0.725 |
| hERG | 0.022 |
| Ames | 0.359 |
| ROA | 0.616 |
| SkinSen | 0.05 |
| Carcinogencity | 0.352 |
| EI | 0.042 |
| Respiratory | 0.034 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.895138 |